Pursuing Hope.
Leading With Science.

Prilenia is dedicated to developing new treatments for the urgent needs facing patients and families with Huntington’s disease, amyotrophic lateral sclerosis (ALS), and other neurodegenerative diseases and neurodevelopmental disorders.
Advancing Potential
Treatments With Purpose.
As we study pridopidine for multiple diseases that originate in the brain, we are uncovering new possibilities and driving research forward to give patients and their families hope.

Harnessing the Brain’s Neuroprotective Capabilities.

Compelling scientific findings show activation of the sigma-1 receptor (S1R) restores pathways in the brain impaired by neurodegenerative diseases.

Get the Latest Information
About Prilenia.

Learn more about Prilenia’s pipeline, scientific progress, and growing business.

Be a Part of
Brighter Futures.

We are aiming to change the lives of patients and their families. Passion, imagination, and innovation make a difference. We need people who are ready to think creatively, collaborate, and do more. If that’s you, let’s talk about working together.